507
Participants
Start Date
September 30, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
May 31, 2013
tasimelteon
20 mg once daily
placebo
once daily
Vanda Investigational Site, New York
Vanda Investigational Site, Staten Island
Vanda Investigational Site, Mount Kisco
Vanda Investigational Site, Brooklyn
Vanda Investigational Site, Rochester
Vanda Investigational Site, Baltimore
Vanda Investigational Site, Atlanta
Vanda Investigational Site, Atlanta
Vanda Investigational Site, Jacksonville
Vanda Investigational Site, Maitland
Vanda Investigational Site, Orlando
Vanda Investigational Site, North Miami
Vanda Investigational Site, Bradenton
Vanda Investigational Site, Memphis
Vanda Investigational Site, Cincinnati
Vanda Investigational Site, Dayton
Vanda Investigational Site, Brown Deer
Vanda Investigational Site, Joliet
Vanda Investigational Site, Chicago
Vanda Investigational Site, Prairie Village
Vanda Investigational Site, Omaha
Vanda Investigational Site, Dallas
Vanda Investigational Site, Austin
Vanda Investigational Site, Denver
Vanda Investigational Site, Salt Lake City
Vanda Investigational Site, Las Vegas
Vanda Investigational Site, Torrance
Vanda Investigational Site, Los Alamitos
Vanda Investigational Site, Sherman Oaks
Vanda Investigational Site, Oceanside
Vanda Investigational Site, San Diego
Vanda Investigational Site, Irvine
Vanda Investigational Site, Garden Grove
Vanda Investigational Site, Oakland
Vanda Investigational Site, Portland
Vanda Investigational Site, Seattle
Vanda Investigational Site, Boston
Vanda Investigational Site, Toms River
Vanda Investigational Site, Willingboro
Vanda Investigational Site, Lincoln
Lead Sponsor
Vanda Pharmaceuticals
INDUSTRY